A citation-based method for searching scientific literature

Yves Pommier, Mark J O'Connor, Johann de Bono. Sci Transl Med 2016
Times Cited: 324



Cherrie K Donawho, Yan Luo, Yanping Luo, Thomas D Penning, Joy L Bauch, Jennifer J Bouska, Velitchka D Bontcheva-Diaz, Bryan F Cox, Theodore L DeWeese, Larry E Dillehay, Debra C Ferguson, Nayereh S Ghoreishi-Haack, David R Grimm, Ran Guan, Edward K Han, Rhonda R Holley-Shanks, Boris Hristov, Kenneth B Idler, Ken Jarvis, Eric F Johnson, Lawrence R Kleinberg, Vered Klinghofer, Loren M Lasko, Xuesong Liu, Kennan C Marsh, Thomas P McGonigal, Jonathan A Meulbroek, Amanda M Olson, Joann P Palma, Luis E Rodriguez, Yan Shi, Jason A Stavropoulos, Alan C Tsurutani, Gui-Dong Zhu, Saul H Rosenberg, Vincent L Giranda, David J Frost. Clin Cancer Res 2007
Times Cited: 570




List of shared articles



Times cited

Radiotherapy-Poly(ADP-ribose) Polymerase Inhibitor Combinations: Progress to Date.
Sarah J Derby, Anthony J Chalmers, Ross D Carruthers. Semin Radiat Oncol 2022
0

Targeting PARP proteins in acute leukemia: DNA damage response inhibition and therapeutic strategies.
Antonella Padella, Andrea Ghelli Luserna Di RorĂ , Giovanni Marconi, Martina Ghetti, Giovanni Martinelli, Giorgia Simonetti. J Hematol Oncol 2022
1

Poly (ADP-ribose) polymerase (PARP) as target for the treatment of epithelial ovarian cancer: what to know.
Luigi Della Corte, Virginia Foreste, Claudia Di Filippo, Pierluigi Giampaolino, Giuseppe Bifulco. Expert Opin Investig Drugs 2021
4

PARP inhibitor olaparib has a potential to increase the effectiveness of electrochemotherapy in BRCA1 mutated breast cancer in mice.
Masa Bosnjak, Tanja Jesenko, Bostjan Markelc, Larisa Janzic, Maja Cemazar, Gregor Sersa. Bioelectrochemistry 2021
2

Veliparib Is an Effective Radiosensitizing Agent in a Preclinical Model of Medulloblastoma.
Jessica Buck, Patrick J C Dyer, Hilary Hii, Brooke Carline, Mani Kuchibhotla, Jacob Byrne, Meegan Howlett, Jacqueline Whitehouse, Martin A Ebert, Kerrie L McDonald,[...]. Front Mol Biosci 2021
3

Therapeutic Potential of PARP Inhibitors in the Treatment of Gastrointestinal Cancers.
Abdullah Alhusaini, Aoife Cannon, Stephen G Maher, John V Reynolds, Niamh Lynam-Lennon. Biomedicines 2021
1